← Leaderboards
David Goldstein
Neurological Disorders And Stroke
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Parkinson Disease”
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$92,426,001
- David M Anderson · University Of Washington$40,483,703
- Daniel M Corcos · Northwestern University$37,632,589
- Joel Synes Perlmutter · Washington University$37,192,743
- Jerrold L Vitek · University Of Minnesota$35,135,315
- Joseph B Martin · Harvard University (Medical School)$26,652,023
Research focus
Parkinson DiseaseDopamineCatecholaminesNoradrenergicNeuronsBrainNorepinephrineAlpha SynucleinLewy Body DiseaseNerve SupplyCardiacPure Autonomic FailuresNeurochemistryNerve DegenerationDepositionNerveDenervationCatecholsLewy BodiesIndexingTyrosine 3-MonooxygenaseNeuroimagingProteinsBase
Grant awards (48)
Biomarkers of Catecholaminergic Neurodegeneration$1,033,335
ZIA · FY2025 · NS · contact PI
Biomarkers of Catecholaminergic Neurodegeneration$1,706,465
ZIA · FY2024 · NS · contact PI
Biomarkers of Catecholaminergic Neurodegeneration$1,854,141
ZIA · FY2023 · NS · contact PI
Biomarkers of Catecholaminergic Neurodegeneration$1,164,021
ZIA · FY2022 · NS · contact PI
Mechanisms of Catecholaminergic Neurodegeneration$405,017
ZIA · FY2022 · NS · contact PI
Treatment of Catecholaminergic Neurodegeneration$233,941
ZIA · FY2022 · NS · contact PI
Biomarkers of Catecholaminergic Neurodegeneration$1,392,826
ZIA · FY2021 · NS · contact PI
Mechanisms of Catecholaminergic Neurodegeneration$487,871
ZIA · FY2021 · NS · contact PI
Treatment of Catecholaminergic Neurodegeneration$248,626
ZIA · FY2021 · NS · contact PI
Autonomic Functions in Post-Acute SARS-CoV-2 (PASC)$22,072
ZIA · FY2021 · NS · contact PI
Biomarkers of Catecholaminergic Neurodegeneration$1,502,893
ZIA · FY2020 · NS · contact PI
Mechanisms of Catecholaminergic Neurodegeneration$593,377
ZIA · FY2020 · NS · contact PI
Treatment of Catecholaminergic Neurodegeneration$376,961
ZIA · FY2020 · NS · contact PI
Biomarkers of Catecholaminergic Neurodegeneration$1,495,643
ZIA · FY2019 · NS · contact PI
Mechanisms of Catecholaminergic Neurodegeneration$586,818
ZIA · FY2019 · NS · contact PI
Treatment of Catecholaminergic Neurodegeneration$373,858
ZIA · FY2019 · NS · contact PI
Biomarkers of Catecholaminergic Neurodegeneration$1,495,263
ZIA · FY2018 · NS · contact PI
Mechanisms of Catecholaminergic Neurodegeneration$615,319
ZIA · FY2018 · NS · contact PI
Treatment of Catecholaminergic Neurodegeneration$384,365
ZIA · FY2018 · NS · contact PI
Biomarkers of Parkinson Disease and Related Disorders$1,073,634
ZIA · FY2017 · NS · contact PI
Mechanisms of Parkinson Disease and Related Disorders$822,424
ZIA · FY2017 · NS · contact PI
Treatment of Catecholamine-Related Disorders$364,558
ZIA · FY2017 · NS · contact PI
Mechanisms of Parkinson Disease and Related Disorders$852,963
ZIA · FY2016 · NS · contact PI
Biomarkers of Parkinson Disease and Related Disorders$682,371
ZIA · FY2016 · NS · contact PI
Treatment of Catecholamine-Related Disorders$170,593
ZIA · FY2016 · NS · contact PI
Mechanisms of Parkinson Disease and Related Disorders$842,411
ZIA · FY2015 · NS · contact PI
Biomarkers of Parkinson Disease and Related Disorders$673,929
ZIA · FY2015 · NS · contact PI
Treatment of Catecholamine-Related Disorders$168,482
ZIA · FY2015 · NS · contact PI
Biomarkers of Parkinson Disease and Related Disorders$857,412
ZIA · FY2014 · NS · contact PI
Mechanisms of Parkinson Disease and Related Disorders$685,930
ZIA · FY2014 · NS · contact PI
Treatment of Catecholamine-Related Disorders$171,482
ZIA · FY2014 · NS · contact PI
Biomarkers of Parkinson Disease and Related Disorders$1,441,785
ZIA · FY2013 · NS · contact PI
Mechanisms of Parkinson Disease and Related Disorders$554,533
ZIA · FY2013 · NS · contact PI
Treatment of Catecholamine-Related Disorders$221,813
ZIA · FY2013 · NS · contact PI
Biomarkers of Parkinson Disease and Related Disorders$1,609,096
ZIA · FY2012 · NS · contact PI
Mechanisms of Parkinson Disease and Related Disorders$459,742
ZIA · FY2012 · NS · contact PI
Treatment of Catecholamine-Related Disorders$229,871
ZIA · FY2012 · NS · contact PI
Biomarkers of Parkinson Disease and Related Disorders$1,568,754
ZIA · FY2011 · NS · contact PI
Mechanisms of Parkinson Disease and Related Disorders$448,215
ZIA · FY2011 · NS · contact PI
Treatment of Catecholamine-Related Disorders$224,108
ZIA · FY2011 · NS · contact PI
Biomarkers of Parkinson Disease and Related Disorders$1,781,723
ZIA · FY2010 · NS · contact PI
Mechanisms of Parkinson Disease and Related Disorders$445,431
ZIA · FY2010 · NS · contact PI
Biomarkers of Parkinson Disease and Related Disorders$1,467,613
ZIA · FY2009 · NS · contact PI
Mechanisms of Parkinson Disease and Related Disorders$366,903
ZIA · FY2009 · NS · contact PI
Biomarkers of Parkinson Disease and Related Disorders$1,766,236
Z01 · FY2008 · NS · contact PI
Mechanisms of Parkinson Disease and Related Disorders$441,559
Z01 · FY2008 · NS · contact PI
Biomarkers of Parkinson Disease and Related Disorders$2,099,276
Z01 · FY2007 · NS · contact PI
Mechanisms of Parkinson Disease and Related Disorders$524,819
Z01 · FY2007 · NS · contact PI